These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30842235)

  • 1. Prognostic Indicators of Recurrence of Bacterial Vaginosis.
    Sobel JD; Kaur N; Woznicki NA; Boikov D; Aguin T; Gill G; Akins RA
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis.
    Hilbert DW; Smith WL; Paulish-Miller TE; Chadwick SG; Toner G; Mordechai E; Adelson ME; Sobel JD; Gygax SE
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):231-42. PubMed ID: 27431434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome.
    Xiao B; Wu C; Song W; Niu X; Qin N; Liu Z; Xu Q
    Front Cell Infect Microbiol; 2019; 9():189. PubMed ID: 31245300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Amsel criteria, Nugent score, culture and two CE-IVD marked quantitative real-time PCRs with microbiota analysis for the diagnosis of bacterial vaginosis.
    van den Munckhof EHA; van Sitter RL; Boers KE; Lamont RF; Te Witt R; le Cessie S; Knetsch CW; van Doorn LJ; Quint WGV; Molijn A; Leverstein-van Hall MA
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):959-966. PubMed ID: 30903536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.
    Bradshaw CS; Morton AN; Hocking J; Garland SM; Morris MB; Moss LM; Horvath LB; Kuzevska I; Fairley CK
    J Infect Dis; 2006 Jun; 193(11):1478-86. PubMed ID: 16652274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
    Front Immunol; 2021; 12():730986. PubMed ID: 34594336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women.
    Sha BE; Chen HY; Wang QJ; Zariffard MR; Cohen MH; Spear GT
    J Clin Microbiol; 2005 Sep; 43(9):4607-12. PubMed ID: 16145114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal analysis of vaginal microbiome dynamics in women with recurrent bacterial vaginosis: recognition of the conversion process.
    Lambert JA; John S; Sobel JD; Akins RA
    PLoS One; 2013; 8(12):e82599. PubMed ID: 24376552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
    Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
    BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study.
    Ratten LK; Plummer EL; Murray GL; Danielewski J; Fairley CK; Garland SM; Hocking JS; Tachedjian G; Chow E; Bradshaw CS; Vodstrcil LA
    BJOG; 2021 Mar; 128(4):756-767. PubMed ID: 33480468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: a pilot study.
    Aguin T; Akins RA; Sobel JD
    Sex Transm Dis; 2014 May; 41(5):290-1. PubMed ID: 24722380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
    Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
    BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial.
    Bangar S; Sonar P; Mane A; Sane S; Kadam A; Katendra TL; Rahane G; Sinha A; Sahay S
    Int J Infect Dis; 2023 Apr; 129():197-204. PubMed ID: 36773716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.
    Fredricks DN; Fiedler TL; Thomas KK; Mitchell CM; Marrazzo JM
    J Clin Microbiol; 2009 Mar; 47(3):721-6. PubMed ID: 19144794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
    Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
    Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benefits of Affirm VPIII and L-PAP in the diagnosis of bacterial vaginosis].
    Flores-Paz R; Rivera-Sánchez R; Ruix-Pérez NJ; Arriaga-Alba M
    Enferm Infecc Microbiol Clin; 2008; 26(6):338-42. PubMed ID: 18588815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.